Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-09-15 Other | 2021-09-17 1:38 pm | N/A N/A | Jounce Therapeutics Inc. | JNCE | Pfeffer Cary Director | 0 | $0 | 50,468 (Indirect) | View |
| 2021-06-18 Option Award | 2021-06-22 4:49 pm | N/A 2031-06-18 | Jounce Therapeutics Inc. | JNCE | Pfeffer Cary Director | 15,700 | $0 | 15,700 (Direct) | View |
| 2021-06-10 Other | 2021-06-14 4:23 pm | N/A N/A | Jounce Therapeutics Inc. | JNCE | Pfeffer Cary Director | 0 | $0 | 35,979 (Indirect) | View |
| 2021-03-11 Other | 2021-03-15 4:15 pm | N/A N/A | Jounce Therapeutics Inc. | JNCE | Pfeffer Cary Director | 0 | $0 | 25,066 (Indirect) | View |
| 2020-11-11 Other | 2020-11-13 8:19 pm | N/A N/A | Jounce Therapeutics Inc. | JNCE | Pfeffer Cary Director | 0 | $0 | 9,917 (Indirect) | View |
| 2020-06-26 Option Award(A) | 2020-07-02 7:37 pm | N/A 2030-06-26 | Jounce Therapeutics Inc. | JNCE | Pfeffer Cary Director | 15,700 | $0 | 15,700 (Direct) | View |
| 2020-06-26 Option Award | 2020-06-29 7:35 pm | N/A 2030-06-26 | Jounce Therapeutics Inc. | JNCE | Pfeffer Cary Director | 13,550 | $0 | 13,550 (Direct) | View |
| 2020-05-06 Disposition | 2020-05-06 9:08 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | Pfeffer Cary Director | 32,500 | $0 | 0 (Direct) | View |
| 2019-06-25 Option Award | 2019-06-27 08:27 am | N/A 2029-06-24 | Neon Therapeutics Inc. | NTGN | Pfeffer Cary Director | 18,500 | $0 | 18,500 (Direct) | View |
| 2019-06-12 Option Award | 2019-06-13 10:31 am | N/A 2029-06-12 | Jounce Therapeutics Inc. | JNCE | Pfeffer Cary Director | 15,700 | $0 | 15,700 (Direct) | View |